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1. Introduction 
Studies [ l-31 employing the potent inhibitor of 
mitochondrial Ca2+ transport, ruthenium red, have 
provided a rational basis for discriminating mito- 
chondrial from non-mitochondrial Ca2+ transport 
by subcellular f actions from rat liver. These have 
been designated ruthenium red-sensitive and ruthenium 
red-insensitive Ca2+ transport components, respectively 
[41. 
In extending initial studies [5,6], we have employed 
initial rat measurements to investigate the properties 
of ruthenium red-insensitive Ca2+ transport in frac- 
tions isolated from rat liver [2,3]. One important 
property we have described relevant o the present 
considerations, i  that intraperitoneal dministration 
of glucagon to rats stimulates by up to 2-fold, the 
initial rate of MgATP-dependent, ruthenium red- 
insensitive Ca2* transport [3]. A stimulation of 
microsomal Ca2+ transport has also been recently 
reported following the exposure of perfused rat liver 
[7] to glucagon. In our studies, the subcellular liver 
fraction most susceptible to the action of the hor- 
mone was enriched with the glucose 6-phosphatase 
activity and was therefore presumably derived from 
the endoplasmic reticulum. It was obtained by 
sedimenting the post-mitochondrial supernatant in
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buffered isoosmotic sucrose at 24 800 X g for 20 min 
[31. 
Because these observations have a direct bearing 
on the mechanism(s) of hormonal control of intra- 
cellular Ca2+ (see also [S]), they have been investigated 
further. The present study shows that incubation of 
hepatocytes with glucagon leads to a stable enhance- 
ment of ruthenium red-insensitive Ca2+ transport. 
2. Experimental procedures 
2.1. Reparation of hepatocytes 
Male Wistar ats (200-250 g) fed ad libitum were 
used in all experiments. The methods of preparation 
and incubation of hepatocytes were those detailed in 
PI. 
2.2. Preparation of membrane fractions 
At the conclusion of the incubation, hepatocytes 
were collected by brief centrifugation i  a bench 
centrifuge (500 X g for 1 min), resuspended in 5 mM 
Hepes buffer (pH 6.8) and homogenized by hand 
using a 40 ml glass Dounce homogenizer (20 strokes). 
The homogenate was resuspended in 250 mM 
sucrose, 5mM Hepes buffer (pH 6.8) plus 0.5 mM 
EGTA and centrifuged at 12 000 X g for 10 min in 
an RC-2B Sorvall centrifuge to remove cell debris, 
nuclei and the bulk of the mitochondria. The super- 
natant fraction was centrifuged at 24 800 X g for 
20 min. This fraction has been designated as the 
‘intermediate fraction’. The resulting supernatant 
31 
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fraction was then centrifuged at 105 000 X g for 
60 min in a Beckman Model L2 Ultracentrifuge to 
yield the ‘microsomal fraction’. 
The pellet obtained from each fractionation step 
was resuspended in an appropriate volume of 250 mM 
sucrose plus 5 mM Hepes (pH 6.8). 
2.3. Protein determination 
Protein content was measured by the method in 
[lo]. Crystalline bovine serum albumin was used as a 
standard. 
2.4. Calcium transport 
Uptake of radioactive Ca2+ was measured by mem- 
brane filtration employing a modification [2] of the 
method in [6]. Transport assays were performed at 
37°C in the following incubation medium: 100 mM 
KCl, 20 mM Hepes buffer (pH 6.8) 5 mM MgC12, 
3.3 mM ammonium oxalate, 2.5 PM ruthenium red 
and 0.3-0.5 mg protein in 1.5 ml final reaction vol. 
After a pre-incubation time of 2 min, 5 mM ATP 
(pH 6.8) was added and the assay was initiated by the 
addition of 5 ~1 10 mM 45Ca2+. At specified time 
intervals, a 100 ~1 sample of the reaction medium 
was removed and filtered through a membrane filter 
(0.45 pm porosity) prewashed with 250 mM sucrose 
plus 5 mM Hepes. The membrane filters were washed 
again to remove non-sequestered 45Ca2t, hen 
dissolved in 10 ml scintillant (6 g butyl PBD in 
400 ml 2.methoxyethanol and 600 ml toluene). 
Radioactivity retained by the filters was measured 
by liquid scintillation spectrometry. The specific 
activity of the radioisotope in each incubation was 
determined by counting an unfiltered 100 ~1 sample. 
2.5. Materials 
45Ca2’ was obtained from the Radiochemical 
Centre, Amersham, Bucks. Ruthenium red purchased 
from Sigma Chemical Co., St Louis, MO was 
recrystallized by the method in [ 111. 
Nucleotides were from Boehringer, Mannheim 
GmbH. ColIagenase (type B) was obtained from 
Worthington Biochemical Corp. (Freehold, NJ). 
Membrane filters (0.45 Irrn porosity) were obtained 
from the Gelman Instrument Company, Ann Arbor, 
MI. 
Glucagon (crystalline), dibutyryl CAMP and 
puromycin dihydrochloride (crystalline) were acquired 
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from Sigma Chemical Co. Crystalline beef insulin was 
from Commonwealth Serum Labs. (Parkville, Victoria). 
All other materials were of analytical reagent grade. 
3. Results 
Two phases of activity characterize ruthenium 
red-insensitive Ca2+ transport by subcellular f actions 
isolated from rat liver [2,3]. The first phase, which is 
rapid and complete by 2-5 min, merges into the 
second which is slower and remains linear for 
> 40 min [2]. Because the second phase is one in 
which considerable cycling of Ca2+ most likely 
occurs, it does not adequately reflect the true ability 
of the vesicles to transport Ca’+. 
Data in fig.lA show the initial phase of Ca2+ 
transport activity by the intermediate fraction 
isolated from rat hepatocytes incubated for 20 min 
with and without glucagon. Exposure of the cells 
to the hormone clearly enhances by - 80% the 
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Fig. lA,lB. Ruthenium red-insensitive Caa+ transport by the 
intermediate and microsomal fractions isolated from rat 
hepatocytes. The incubation medium used in the Caz+ ’ 
transport studies contained in 1.5 ml final vol.: 100 mM 
KCl, 20 mM Hepes buffer (pH 6.8), 3.3 mM ammonium 
oxalate, 5 mM ATP, 5 mM MgCL, ,2.5 MM ruthenium red 
and 0.3 -0.5 mg protein. The reaction was initiated by the 
addition of 50 nmol Ca*+ dontaining 0.5 /&i “Caa+, The 
reaction was at 37% For further details see section 2. 
Hepatocytes were incubated at 37°C in Krebs-Henseleit 
buffer gassed with 0, , CO, (955) for 20 min in the 
presence of 5 X lo-’ M glucagon (Glu) (0) and in the 
absence of hormone (Sal) (*), prior to preparation of the 
subcellular fractions. Results shown are from a representative 
experiment. 
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initial rate of ruthenium red-insensitive Ca2+ transport 
by this fraction. 
In contrast, glucagon treatment of hepatocytes did 
not significantly increase the initial phase of 
ruthenium red-insensitive Cap transport activity by 
the microsomal fraction (fig.lB). A lack of effect of 
glucagon on the Ca2+ transport activity of the micro- 
somal fraction was reported in an earlier study where 
the hormone was administered invivo [3]. In these 
earlier studies, total Ca2’ transport activity was 
greater in the microsomal fraction than in the inter- 
mediate fraction. In this study, Ca2’ transport activity 
was higher in the intermediate fraction, possibly as a 
result of the general instability of the microsomal 
fraction isolated from hepatocytes (W.M.T., F.L.B., 
unpublished). 
Data in fig.2 show that the extent to which 
glucagon promotes an increase in ruthenium red- 
insensitive Ca’+ transport by the intermediate frac- 
tion, is dependent on the concentration of glucagon 
added to the cell suspension..Half-maximal and
maximal effects occur at - 5 X 10m9 M glucagon 
and IO-’ M glucagon, respectively. 
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Fig.2. Ruthenium red-insensitive Caa+ transport by the 
intermediate fraction isolated from rat hepatocytes pre- 
exposed to varying glucagon concentrations. Caa* transport 
was measured as in fii.1. Hepatocytes were incubated for 
20 min at 37°C with glucagon present at the concentrations 
indicated before preparation of the intermediate fraction. 
Results are expressed as the mean f SEM for the no. expts 
indicated in parentheses. 
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Fig.3. Ruthenium red-insensitive Ca*+ transport by the 
intermediate fraction isolated from rat hepatocytes Pre- 
exposed to glucagon for varying time periods. Ca*’ transport 
was measured as in fii.1. Hepatocytes were incubated in the 
presence of 5 x lo-’ M glucagon for the times indicated. 
Results are expressed as the mean + SEM for the no. expts 
shown in parentheses. 
The effect of time of incubation of the cells with 
a fixed concentration of glucagon (5 X lo-’ M) on 
the stimulation of Ca2+ transport is shown in fig.3. 
No response is seen until after 5 min exposure to the 
hormone. By 10 min, the initial rate of Ca*+ transport 
is stimulated > 50% and by 20 min it has reached 
maximal stimulation. Thereafter the degree of 
stimulation gradually falls away. 
A comparison of the effects of incubation of the 
cells with glucagon, insulin or dibutyryl CAMP on 
the Ca2’ transport activity of the intermediate frac- 
tion is shown in table 1. Although insulin treatment 
alone had no significant effect on the ruthenium red- 
insensitive Ca2+ transport activity subsequently 
determined in the intermediate fraction, co- 
administration of the hormone with glucagon com- 
pletely abolished the stimulatory effect of glucagon 
described above. Treatment of hepatocytes with 
dibutyryl CAMP led to a stimulation of Ca2’ transport 
activity in the intermediate fraction similar to that 
observed after treatment of cells with glucagon. 
4. Discussion 
The experiments described here clearly establish 
33 
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Table 1 
Effects of glucagon, insulin, glucagon plus insulin and 
dibutyryl CAMP on Caz+ transport in intermediate fraction 
Addition Stimulation of initial rate of 
Ca2” uptake (% increase over 
control) 
None 0 
Glucagon 69* 8a 
Insulin 25 i 22 
Glucagon + insulin 15 + 13 
Dibutyryl CAMP 71+ 19a 
an < 0.01 compared to control 
For details of hepatocyte incubation and intermediate 
fraction preparation see i”rr. 1 A. Where indicated, additions 
were made at the following fmal cont.: glucagon 5 X lo-’ M; 
insulin 3 x 10sp M (1 mu/ml); dibutyryl CAMP 5 X 10T4 M. 
Results are expressed as mean f SEM for 7 separate xpts, 
each assayed in duplicate 
that the exposure of rat hepatocytes to low concen- 
trations of glucagon induces a considerable enhance- 
ment of ruthenium red-insensitive Ca2* transport in 
the intermediate ( ndoplasmic reticulum-rich) frac- 
tion isolated from the cells. The in vitro effects 
reported here are remarkably similar to those seen 
following administration of glucagon to adult and 
prenatal rats in vivo [3]. This enhances the likelihood 
that glucagon itself is the hormone primarily 
responsible for inducing the changes in ruthenium 
red-insensitive Ca2+ transport in the in vivo situation 
]3]. 
The observations that glucagon acts relatively 
rapidly, is effective at low concentrations, and that its 
effect is orbited by insulin, suggest that these 
findings may be of physiological consequence. The 
effect probably also represents a mechanism by which 
glucagon stimulates the short-term redistribution of 
intrace~ular Ca2’, which may be lied to the effect 
of the hormone on gluconeogenesis [12-141. 
A further observation of note is the stimulation 
of ruthenium red-insensitive Ca2+ transport activity 
by dibutyryl CAMP. This result indicates apossible 
involvement of CAMP in the stimulation of Ca2* 
transport activity and is the subject of further 
investigation. 
Finally, as observed (F.L.B., P. A. Jacomb, unpub- 
lished) [3], it is important o appreciate that the 
glucagon-sensitive Ca2’ transport system resides in the 
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intermediate fraction and not in the fraction obtained 
by high-speed centrifugation, even though both 
membrane fractions appear to be derived from the 
endoplasmi~ reticulum (F. L. B., P. A. Jacomb, 
unpublished) [3]. These properties are of interest in 
that they are analogous to those of the ruthenium red- 
sensitive CaZS transport system, which is also modified 
by glucagon action 131, and has a heterogeneous 
distribution among mitochondrial populations in rat 
liver [15]. 
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